1007-8134
2009 Issue 4
Insights on the management of public health emergencies of infectious diseases hospitals
Shi Jianfei
Shi Jianfei
..............page:237-240
..............page:247-249
Role of PD-1/PD-L in regulating immune responses
Chen Ji;Wang Guiqiang
Chen Ji;Wang Guiqiang
..............page:240-243
Rescue treatment of adefovir dipivoxil for lamivudine-resistant CHB patients
su ming hua ; jiang jian ning ; liu zhi hong ; zhang zuo ; deng yi ming ; ge shan fei ; jiang zi cheng ; hu jia guang ; zhu mei qin
su ming hua ; jiang jian ning ; liu zhi hong ; zhang zuo ; deng yi ming ; ge shan fei ; jiang zi cheng ; hu jia guang ; zhu mei qin
..............page:227-229
Effect of oxymatrine on the expression of relevant cytokines in patients with chronic hepatitis B
Zhou Hongyan;Zhang Bo;Wang Zheng
Zhou Hongyan;Zhang Bo;Wang Zheng
..............page:230-232
..............page:255-256
..............page:218,221
..............page:233-234
Therapeutic effect of different durations of IFN-α treatment for HBeAg-positive chronic hepatitis B and 3 years of follow-up
li xu hong ; lai jiang qiong ; li zuo zuo ; wang chong guo
li xu hong ; lai jiang qiong ; li zuo zuo ; wang chong guo
..............page:222-224
Advances in receptors and molecules associated with the entry of HCV into host cells
Zhang Jiueong;Sun Li;Nie Qinghe
Zhang Jiueong;Sun Li;Nie Qinghe
..............page:250-254
3 cases of peripheral neuropathy induced by telbivudine
Du Ning;Hu Jinhua;Wang Huifen
Du Ning;Hu Jinhua;Wang Huifen
..............page:254-255
Efficacy and response prediction in the treatment of HBeAg-positive chronic hepatitis B with interferon alpha-2b
xu jing hang ; yu yan yan ; si chong wen ; chen xin yue ; han zhong hou ; chen yong ; zhang wen zuo ; chen yu ping ; li xue ying
xu jing hang ; yu yan yan ; si chong wen ; chen xin yue ; han zhong hou ; chen yong ; zhang wen zuo ; chen yu ping ; li xue ying
..............page:211-215
Purified HBV promoting Smad3 expression in human hepatic stellate cell line LX-2 cells
wu xiao ning ; bai qi xuan ; liu tian hui ; li jia ; you hong ; jia ji dong
wu xiao ning ; bai qi xuan ; liu tian hui ; li jia ; you hong ; jia ji dong
..............page:203-206
Thinking on antiviral therapy for chronic hepatitis B
Wang Yu;Jia Jidong
Wang Yu;Jia Jidong
..............page:193-195
..............page:243-246
Follow-up study on serological detection of anti-SARS-CoV IgG/IgM antibody and its significance
wang hai bin ; jiang su chun ; wang er ping ; zhou xian zhi ; li yong li ; zhao min
wang hai bin ; jiang su chun ; wang er ping ; zhou xian zhi ; li yong li ; zhao min
..............page:235-237
Role of HBeAg level and its decreasing rate in antiviral therapy
Wang Guishuang;Cai Haodong
Wang Guishuang;Cai Haodong
..............page:224-227
Generation and analysis of HBcAg-specific CTL clones in a patient with acute hepatitis B
zheng ji shan ; he chang lun ; wang shou ming ; zhang yi hong ; tang yu de ; dai yu dong
zheng ji shan ; he chang lun ; wang shou ming ; zhang yi hong ; tang yu de ; dai yu dong
..............page:200-202,206
..............page:196-199
Mutations possibly associated with tenofovir disoproxil fumarate resistance in 1 740 patients with chronic hepatitis B
liang zhao ling ; liu zuo ; su he ling ; meng yu hua ; luo li rong ; wang jing ; dai jiu zeng ; yao zeng tao ; xu dong ping
liang zhao ling ; liu zuo ; su he ling ; meng yu hua ; luo li rong ; wang jing ; dai jiu zeng ; yao zeng tao ; xu dong ping
..............page:207-210
Correlation between the efficacy of adefovir dipivoxil on HBeAg-negative patients with chronic hepatitis B and HBV genotypes
hu zhang yong ; yang jun ; xu ying ; xia shao bi ; liu fu yuan
hu zhang yong ; yang jun ; xu ying ; xia shao bi ; liu fu yuan
..............page:219-221
Therapeutic effect of 48 weeks of telbivudine on HBeAg-positive chronic hepatitis B
chen shi xiao ; hu xiao zhong ; zhu fan ; wan bin ; liu ping
chen shi xiao ; hu xiao zhong ; zhu fan ; wan bin ; liu ping
..............page:216-218